Profile
Corporate information
Official name
ACT Genomics Co Ltd
Registration country
Investment activity status
Active investor
Company type
Provider of cancer molecular information solutions.Funding
Funding rounds
Series B USD 12,500,000
USD 12,500,000 (6 May 2016)
ACT Genomics plans to use the proceeds to further boost the capacity to support the rapid growth and expansion in Japan, Taiwan, Singapore, Malaysia, Thailand, and Hong Kong. The new proceeds will also enable ACT Genomics to ramp up its commercial channel
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
CDIB Capital Management | Led the round. | ||
|
Hotung Group | Led the round. | ||
|
|
Eminent II VC | Follow-on investment. Round participant. | ||
|
|
Hua Nan Venture Capital | Follow-on investment. Round participant. | ||
|
|
President International Development Corp | Follow-on investment. Round participant. | ||
|
UMC Capital | Follow-on investment. Round participant. |